Condition

Kaposi Sarcoma

ClinicalTrials.gov condition label

Clinical trials28

Recruiting11

Common interventions25

Lead sponsors shown14

Clinical trials

28 shown

Precision Imaging to Evaluate Kaposi SarcomaNCT06898203 · 2026-04-10

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)NCT07308886 · 2026-04-08

Propranolol for the Treatment of Kaposi Sarcoma in AdultsNCT06445166 · 2025-08-20

Agnostic Therapy in Rare Solid TumorsNCT06638931 · 2024-07-16

Natural History Study of Kaposi SarcomaNCT06375122 · 2024-05-15

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)NCT06004011 · 2024-05-01

Trial of Ixazomib for Kaposi SarcomaNCT04305691 · 2023-11-07

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersNCT05663502 · 2023-05-10

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVNCT04902443 · 2021-12-10

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi SarcomaNCT04941274 · 2021-09-29

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaNCT04303117 · 2020-07-13

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNCT07576725 · 2026-12-01

NOT_YET_RECRUITING

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaNCT05411237 · 2026-09-01

NOT_YET_RECRUITING

Kaposi Sarcoma Chemotherapy and Research (KS-CARE)NCT06480773 · 2023-04-25

ACTIVE_NOT_RECRUITING

NT-I7 for Kaposi Sarcoma in Patients With or Without HIVNCT04893018 · 2022-05-23

HHV8 and Solid Organ TransplantationNCT05081141 · 2021-09-15

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal AnalysisNCT04742387 · 2021-02-04

ACTIVE_NOT_RECRUITING

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi SarcomaNCT03316274 · 2018-05-07

Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western KenyaNCT03404297 · 2018-03-01

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)NCT03157167 · 2017-12-01

Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in MalawiNCT03160183 · 2016-09-01

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerNCT02595866 · 2016-04-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi SarcomaNCT02659930 · 2016-01-13

ACTIVE_NOT_RECRUITING

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNCT02408861 · 2015-10-21

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.NCT03296553 · 2015-10-01

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi SarcomaNCT02229981 · 2014-07-01

Pomalidomide for Kaposi Sarcoma in People With or Without HIVNCT01495598 · 2012-01-10

Development of Serologic Assays for Human Herpes Virus-8NCT00395278 · 2006-10-30

Common interventions

Leading sponsors

National Cancer Institute (NCI)10 AIDS Malignancy Consortium3 Fred Hutchinson Cancer Center2 UNC Lineberger Comprehensive Cancer Center2 Washington University School of Medicine2 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Implenomics1 Indiana University1 Instituto do Cancer do Estado de São Paulo1 National Institute of Cancerología1 National Institutes of Health Clinical Center (CC)1 Navidea Biopharmaceuticals1 RedHill Biopharma Limited1 University of California, San Francisco1

Trial status mix

RECRUITING11

COMPLETED8

ACTIVE_NOT_RECRUITING3

NOT_YET_RECRUITING2

TERMINATED2

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE110

PHASE210

NA3

EARLY_PHASE11

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.